Wednesday, June 10, 2026

pharma · No medical condition.

BIAL - Portela

BIAL - Portela patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

TROFA, PT HQ
EMA registrant Type
Company details
Status
Public
HQ
TROFA, PT
Programs
4
Drugs
9
Patents
25
Intelligence · Patents

BIAL - Portela patents

25 pharmaceutical patents indexed for BIAL - Portela. 0 expire within 24 months.

BIAL - Portela has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. WO 2026106499

    ANTAGONISTES DU RÉCEPTEUR DE L'ORÉXINE : COMPOSÉS 2-AZABICYCLIQUES

    Expires Wed May 16 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. WO 2026015039

    THÉRAPIE GÉNIQUE POUR LE TRAITEMENT DE L'ENCÉPHALOPATHIE ÉPILEPTIQUE ASSOCIÉE À LA SYNGAP1

    Expires Wed Jan 10 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. WO 2025211975

    AGONISTES DU RÉCEPTEUR DE L'OREXINE

    Expires Wed Oct 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. WO 2025023851

    ANTAGONISTES DU RÉCEPTEUR DE L'OREXINE MORPHOLINE

    Expires Wed Jan 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. WO 2025023852

    ANTAGONISTES DU RÉCEPTEUR DE L'OREXINE MORPHOLINE

    Expires Wed Jan 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. WO 2024242579

    RÉGIMES DE TRAITEMENT DE LA MALADIE DE PARKINSON IDIOPATHIQUE PRÉCOCE

    Expires Wed Nov 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. AU 2023244944

    PRODRUGS OF OPICAPONE

    Expires Wed Sep 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. WO 2024039256

    RÉGIMES THÉRAPEUTIQUES POUR LA MALADIE DE PARKINSON

    Expires Wed Feb 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. KR 20230088753

    파킨슨병 치료를 위한 오피카폰 및 레보도파

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. KR 20230047080

    오피카폰의 고체 분산물

    Expires Wed Apr 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. WO 2022158991

    TRAITEMENT DE LA DOULEUR ASSOCIÉE À LA MALADIE DE PARKINSON AVEC DE L'OPICAPONE EN COMBINAISON AVEC LA LÉVODOPA

    Expires Wed Jul 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. WO 2022131944

    RÉGIMES DE TRAITEMENT DE LA MALADIE DE PARKINSON IDIOPATHIQUE PRÉCOCE

    Expires Wed Jun 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. CA 3183290

    COMPRIME COMPRENANT DE L'OPICAPONE

    Expires Wed Nov 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 2021338651

    METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS

    Expires Wed Oct 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. CA 3174918

    OPICAPONE MICRONISEE

    Expires Wed Sep 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. CA 3142348

    INHIBITEURS DE DOPAMINE-B-HYDROXYLASE

    Expires Wed Dec 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. CA 3103212

    FORMULATIONS COMPRENANT DES INHIBITEURS DE LA DOPAMINE-S-HYDROXYLASE ET LEURS PROCEDES DE PREPARATION

    Expires Wed Dec 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 2019337950

    BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-B-HYDROXYLASE INHIBITORS

    Expires Wed Nov 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. CA 3082337

    INHIBITEURS DE DOPAMINE-B-HYDROXYLASE

    Expires Wed Jun 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 2017340593

    MEDICAMENTS FOR SLOWING PARKINSON'S DISEASE

    Expires Wed Nov 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. EP 3044215

    VERFAHREN ZUR HERSTELLUNG VON MEDIKAMENTEN ZUR BEHANDLUNG VON KARDIOVASKULÄREN ERKRANKUNGEN UND DARIN VERWENDETE ZWISCHENPRODUKTE

    Expires Tue Jul 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. EP 3024825

    IMIDAZOLECARBOXAMIDE UND IHRE VERWENDUNG ALS FAAH INHIBITOREN

    Expires Tue May 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. TW 201536770

    Urea compounds and their use as enzyme inhibitors

    Expires Wed Sep 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. CA 2919844

    COMPOSES D'UREE ET LEUR UTILISATION COMME INHIBITEURS DE L'ENZYME FAAH

    Expires Wed Jan 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. CA 2908706

    TRAITEMENTS UTILISANT L'ESLICARBAZEPINE ET L'ACETATE D'ESLICARBAZEPINE

    Expires Wed Oct 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does BIAL - Portela have?

25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do BIAL - Portela patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.